Adverse Drug Event Clinical Trials

9 recruiting

Adverse Drug Event Trials at a Glance

10 actively recruiting trials for adverse drug event are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Beijing, Delray Beach, and Ioannina. Lead sponsors running adverse drug event studies include Capital Medical University, Complejo Hospitalario Universitario de Badajoz, and Beijing Shijitan Hospital, Capital Medical University.

Browse adverse drug event trials by phase

Treatments under study

About Adverse Drug Event Clinical Trials

Looking for clinical trials for Adverse Drug Event? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Adverse Drug Event trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Adverse Drug Event clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting

Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia

Pediatric CancerToxicity, DrugALL, Childhood+5 more
University of Geneva, Switzerland556 enrolled2 locationsNCT05512169
Recruiting
Not Applicable

The Geriatric Emergency Department Pharmacologic Harm Prevention Project

Adverse Drug EventsPoly PharmacyFall+3 more
Florida Atlantic University1,000 enrolled1 locationNCT07216846
Recruiting
Phase 4

Sedation Efficacy and Safety of Remazolam Besylate in Ventilated Surgical Critically Ill Patients

SurgeryMechanical Ventilation ComplicationCritical Illness+3 more
Beijing Shijitan Hospital, Capital Medical University306 enrolled1 locationNCT06575530
Recruiting
Phase 3

Melatonin for Prevention of Kidney Injury

Acute Kidney InjuryAdverse Drug Event
Rutgers, The State University of New Jersey300 enrolled2 locationsNCT05084196
Recruiting
Not Applicable

Comparative Study of Tranexamic Acid Dosing in Cardiac Surgery

Adverse Drug EventFibrinolysis; HemorrhageBlood Coagulation Disorder+2 more
University of Ioannina150 enrolled1 locationNCT07164300
Recruiting

Evaluation of the Implementation of the Pharmacogenetics and Personalized Medicine Program "MedeA" in the Extremadura Health Service.

Adverse Drug Event
Complejo Hospitalario Universitario de Badajoz6,445 enrolled1 locationNCT06607445
Recruiting

Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib)

Adverse Drug EventDrug UseDrug Side Effect+3 more
Universidade do Porto150 enrolled3 locationsNCT06498167
Recruiting
Phase 1

Oncolytic Virus Ad-TD-nsIL12 for Progressive Pediatric Diffuse Intrinsic Pontine Glioma

Adverse Drug EventDiffuse Intrinsic Pontine GliomaOncolytic Virus
Capital Medical University18 enrolled1 locationNCT05717699
Recruiting
Phase 1

Oncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic Pontine Glioma

Adverse Drug EventDiffuse Intrinsic Pontine GliomaOncolytic Virus
Capital Medical University18 enrolled1 locationNCT05717712
Recruiting
Not Applicable

Effect of NST Whole-course Nutritional Management on Nutritional Status and Adverse Reactions in Esophageal Cancer

Esophageal NeoplasmsAdverse Drug Event
The First Affiliated Hospital with Nanjing Medical University210 enrolled1 locationNCT05800054